Case Control in Sarcopenia Among Elderly Type 2 Diabetic Patients

Eman Alaa Eldean Mohamed

Status: Not yet enrolling

Conditions: Sarcopenia

Treatments: Diagnostic Test: muscle ultrasound

Study type: Observational

Funder types: Other

Identifiers

NCT07244601

sarcopenia in elderly diabetic

Details and patient eligibility

About

1. Assess sarcopenia prevalence in elderly diabetic patients.
2. Evaluate impact of diabetes and its medications on muscle health.
3. detect effect of sacropenia on quality of life on elderly

Enrollment: 100 estimated patients

Sex: All

Ages: 65+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

1. Inclusion criteria:

   The study will included all patient ,age ≥ 60 years,diagnosed with type 2 diabetes mellitus at least 5 years duraation according to ADA guideline referance(8) (diabetes can be made if a patient's A1C is 6.5% or higher, their FPG is 126 mg/dL or higher, or their 2-hour plasma glucose during an OGTT is 200 mg/dL or higher. A random plasma glucose of 200 mg/dL or higher, in conjunction with classic symptoms of hyperglycemia, also indicates diabetes)

   ●Able to give informed consent

2. Exclusion criteria:

   • chronic renal disease
   • chronic liver disese
   • Severe cognitive impairment
   • Known neuromuscular diseases affecting mobility
   • malignancy Data of the study will collected over one year duration from 1/2026 _1/2027

Trial design

100 participants in 2 patient groups

Diabetic Group

Description:

Elderly patients with type 2 diabetes mellitus. Participants will be evaluated for the presence or absence of sarcopenia using muscle ultrasound and clinical criteria.

Treatment:

Diagnostic Test: muscle ultrasound

Non-Diabetic Group

Description:

Elderly patients without diabetes mellitus. Participants will also be assessed for sarcopenia using muscle ultrasound and standard diagnostic criteria.

Treatment:

Diagnostic Test: muscle ultrasound